Sector-Specific Valuation Expertise
Sector-Specific Valuation Expertise
Cannabis Valuation
Featured Sector
Specialized cannabis business valuations for licensed cultivators, processors, dispensaries, and multi-state operators (MSOs). We model IRC §280E tax burdens, state-by-state licensing risk premiums, and the unique capital structures of plant-touching businesses to deliver defensible, audit-ready opinions of value.
- 409A valuations for cannabis MSOs and vertically integrated operators
- Purchase price allocations (ASC 805) for cannabis license acquisitions
- Goodwill impairment testing (ASC 350) under regulatory volatility
- Fairness opinions for cannabis M&A and SPAC transactions
- Gift & estate valuations for founder equity in cannabis operators
Oil & Gas Valuation
Featured Sector
Upstream, midstream, and downstream oil and gas valuations grounded in third-party reserve engineering reports, NYMEX strip pricing, and PV-10 / PV-15 analysis. We value working interests, mineral and royalty rights, ORRIs, NPIs, and oilfield services companies for tax, financial reporting, and transaction purposes.
- Reserve-based valuations (PDP, PDNP, PUD, PROB) using SEC pricing
- Purchase price allocations (ASC 805) for E&P acquisitions
- Mineral & royalty interest fair market value opinions
- Impairment testing for proved and unproved oil & gas properties
- Fairness opinions for upstream, midstream, and OFS transactions
Oil & Gas Valuation
Featured Sector
Upstream, midstream, and downstream oil and gas valuations grounded in third-party reserve engineering reports, NYMEX strip pricing, and PV-10 / PV-15 analysis. We value working interests, mineral and royalty rights, ORRIs, NPIs, and oilfield services companies for tax, financial reporting, and transaction purposes.
- Reserve-based valuations (PDP, PDNP, PUD, PROB) using SEC pricing
- Purchase price allocations (ASC 805) for E&P acquisitions
- Mineral & royalty interest fair market value opinions
- Impairment testing for proved and unproved oil & gas properties
- Fairness opinions for upstream, midstream, and OFS transactions
Cannabis Valuation
Featured Sector
Specialized cannabis business valuations for licensed cultivators, processors, dispensaries, and multi-state operators (MSOs). We model IRC §280E tax burdens, state-by-state licensing risk premiums, and the unique capital structures of plant-touching businesses to deliver defensible, audit-ready opinions of value.
- 409A valuations for cannabis MSOs and vertically integrated operators
- Purchase price allocations (ASC 805) for cannabis license acquisitions
- Goodwill impairment testing (ASC 350) under regulatory volatility
- Fairness opinions for cannabis M&A and SPAC transactions
- Gift & estate valuations for founder equity in cannabis operators
Additional Sectors
Technology & SaaS
Early-stage to pre-IPO 409A valuations, ASC 718 stock comp, and ASC 805 PPAs for software, AI, and SaaS companies.
Healthcare & Life Sciences
Biotech, medtech, digital health, and provider group valuations with milestone risk and probability-weighted cash flow modeling.
Consumer & Retail
DTC brands, franchise systems, and CPG portfolio valuations using market multiples and DCF.
Industrials & Manufacturing
Equipment-heavy operations with tangible and intangible asset allocations under ASC 805.
Financial Services
Asset managers, RIAs, insurance carriers, and specialty finance company valuations.
Energy & Renewables
Solar, wind, battery storage, and traditional power generation project and platform valuations.
Technology & SaaS
Early-stage to pre-IPO 409A valuations, ASC 718 stock comp, and ASC 805 PPAs for software, AI, and SaaS companies.
Healthcare & Life Sciences
Biotech, medtech, digital health, and provider group valuations with milestone risk and probability-weighted cash flow modeling.
Consumer & Retail
DTC brands, franchise systems, and CPG portfolio valuations using market multiples and DCF.
Technology & SaaS
Early-stage to pre-IPO 409A valuations, ASC 718 stock comp, and ASC 805 PPAs for software, AI, and SaaS companies.
Healthcare & Life Sciences
Biotech, medtech, digital health, and provider group valuations with milestone risk and probability-weighted cash flow modeling.
Consumer & Retail
DTC brands, franchise systems, and CPG portfolio valuations using market multiples and DCF.
Don't see your industry?
valuation needs.